Active, not recruitingNCT07163000

Earlier Diagnosis of Peripheral Neuropathy Using A Simple sCreening Tool (ACT)

Studying Paraneoplastic neurologic syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Weill Cornell Medical College in Qatar
Principal Investigator
Professor Rayaz A. Malik, PhD
Weill Cornell Medicine - Qatar
Enrollment
150 target
Eligibility
18 years · All sexes
Timeline
2025 – 2026

Study locations (1)

Collaborators

Procter and Gamble · Hamad Medical Corporation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07163000 on ClinicalTrials.gov

Other trials for Paraneoplastic neurologic syndrome

Additional recruiting or active studies for the same condition.

See all trials for Paraneoplastic neurologic syndrome →

← Back to all trials